These days if some of those whose footsteps first trod this valley could come back, they would still recognize a valley that hasn’t altered much with the passing of time.
Spero's chief executive Ankit Mahadevia said that the company remains committed to tebipenem, despite its shift in focus to SPR720, an oral therapy for the treatment of a rare pulmonary disease ...